Maria I. Vera
Majadahonda, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry.
Journal: Digestive diseases (Basel, Switzerland)
Published: September 13, 2023
IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
Journal: Digestive diseases and sciences
Published: July 28, 2023
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.
Journal: Journal of Crohn's & colitis
Published: December 01, 2021
Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis.
Journal: Clinical and translational gastroenterology
Published: November 18, 2021
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 27, 2021
Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing.
Journal: European journal of gastroenterology & hepatology
Published: August 02, 2021
Organoplatinum(II) Complexes Self-Assemble and Recognize AT-Rich Duplex DNA Sequences.
Journal: Inorganic chemistry
Published: January 27, 2021
Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit.
Journal: Revista espanola de enfermedades digestivas
Published: December 21, 2020
Comparison of original and biosimilar infliximab (CTP-13) in biologic-naïve patients with Crohn's disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain.
Journal: Revista espanola de enfermedades digestivas
Published: November 20, 2020
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Journal: Inflammatory bowel diseases
Published: April 02, 2019
Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
Journal: Digestive diseases and sciences
Published: August 01, 2017
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
Journal: The American journal of gastroenterology
Published: April 13, 2017
Last Updated: 09/26/2026